Key result
Among 101 patients with perimembranous ventricular septal defects followed without closure, 21 met the eligibility criteria for minimally-invasive percutaneous closure using the ADO I.
Observational (n=359)
Answers are grounded in this paper and cite their sources.
背景:膜様部心室中隔欠損(pmvsd)に対する経皮的カテーテル閉鎖術の報告が増加しているが,現在日本における治療方法は外科手術のみである.
No takes yet. Share an insight, caveat, or question.
Asada et al. (2019) conducted an observational in Ventricular septal defect (VSD) (n=359). Eligibility for percutaneous closure with Amplatzer duct occluder I (ADO I) was evaluated on Proportion of patients with unclosed perimembranous VSD meeting eligibility criteria for percutaneous closure. Among 101 patients with perimembranous ventricular septal defects followed without closure, 21 met the eligibility criteria for minimally-invasive percutaneous closure using the ADO I.
Synapse has enriched 10 related papers. Consider them for comparative context: